跳至主要内容
临床试验/NCT03816384
NCT03816384撤回不适用

Effect of Active Drain Line Clearance With or Without Silver on Catheter-Associated Bacteriuria (The CAB Study)

Potrero Medical0 个研究点开始时间: 2020年1月31日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
Difference in percentage of catheter-associated bacteriuria

研究概览

简要总结

Catheter-associated urinary tract infections (CAUTI) are the most common nosocomial infections in critically ill patients and are responsible for high morbidity rates, increased hospital stays and associated costs.

The purpose of this study is to evaluate whether active drain line clearance by the Accuryn Monitoring System reduces the incidence of CAUTI in hospitalized patients requiring catheters.

详细描述

Urinary tract infection (UTI) is the most common healthcare associated infection (HAI) acquired in hospitals and is estimated to account for approximately 13% of hospital infections in the United States, of which 75% are associated with indwelling urinary catheters. It is estimated that between 12-16% adult inpatients will receive an indwelling urinary catheter during their hospital stay. The rate of catheter-associated UTI (CAUTI) are highest in burn ICUs, followed by inpatient medical wards and neurosurgical ICUs.

The purpose of this study is to evaluate whether active drain line clearance by the Accuryn Monitoring System reduces the incidence of bacteriuria and/or CAUTI in patients requiring catheters for more than 72 hours. This study will also evaluate the efficacy in reducing bacteriuria of the Accuryn silver fabricated silicone catheters.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (age ≥ 18)
  • Patient or Legally Authorized Representative (LAR) possess the capacity to provide informed consent
  • Indication for a urinary bladder catheter (or one currently in place)
  • Expected urinary catheter requirement ≥ 72 hours
  • No current urinary tract infection
  • No current indication for prophylactic antibiotics. If a surgical patient, receive perioperative antibiotics for no greater than 24 hours

排除标准

  • Inability to receive a urinary bladder catheter
  • Chronic suprapubic catheter in place
  • Expected survival < 72 hours
  • Receipt of systemic antibiotics within 48 hours of enrollment, other than prophylactic antibiotics given at the time of surgery
  • Surgery of the genitourinary tract in the past 6 months prior to admission
  • Deemed unfit for the protocol by the investigator for any reason

结局指标

主要结局

Difference in percentage of catheter-associated bacteriuria

时间窗: 30 days

To study the difference in rate of catheter-associated bacteriuria between SOC catheters and Accuryn silicone or Accuryn silver-doped catheters with active drain line clearance.

次要结局

  • Urine Culture Comparisons(30 days)
  • Percentage of asymptomatic (ASB) and symptomatic (CAUTI) bacteriuria(30 days)
  • Time to Bacteriuria (ASB and CAUTI)(30 days)

研究者

发起方
Potrero Medical
申办方类型
Industry
责任方
Sponsor

相似试验